SCOTUS denies review of GSK, Teva competition case

08-11-2016

SCOTUS denies review of GSK, Teva competition case

Gary Blakeley / Shutterstock.com

The US Supreme Court yesterday denied a petition for certiorari in a case centring on Lamictal (lamotrigine), a treatment for certain types of seizures as well as bipolar disorder.


:SCOTUS, Lamictal, lamotrigine, GSK, Teva, settlement, antitrust,

LSIPR